Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 53, Issue 4, 2014, Pages 325-336

  Wu, Xiaofeng ^a   Chen, Hairong ^b   Gao, Qiang ^c,d   Bai, Jin ^b   Wang, Xiaoying ^c,d   Zhou, Jian ^c,d   Qiu, Shuangjian ^c,d   Xu, Yang ^c,d   Shi, Yinghong ^c,d   Wang, Xuehao ^a   Zhou, Jianwei ^b   Fan, Jia ^c,d  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Carcinoma, hepatocellular; JWA; Metastasis; Neoplasm invasion; Prognosis

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; JWA PROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; MIDDLE AGED; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; JWA; METASTASIS; NEOPLASM INVASION; PROGNOSIS;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; DOWN-REGULATION; ENZYME ACTIVATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84895795206     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21981     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359:378-390.
3. Zhou JW, Di YP, Zhao YH, Wu R. Investigation on cell modulation: Signal transduction, apoptosis and gene expression. In: Ye XS, Shen BF, Tang XF, editors. Investigation on cell modulation: Signal transduction, apoptosis and gene expression. Beijing: Military Medical Sciences Press; 1999. pp. 110-119.
4. Schweneker M, Bachmann AS, Moelling K. JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett 2005; 579:1751-1758.
5. Butchbach ME, Lai L, Lin CL. Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene 2002; 292:81-90.
6. Zhu YJ, Li CP, Tang WY, Li AP, Liu QZ, Zhou JW. Single nucleotide polymorphism of the JWA gene is associated with risk of leukemia: A case-control study in a Chinese population. J Toxicol Environ Health A 2007; 70:895-900.
7. Li CP, Zhu YJ, Chen R, et al. Functional polymorphisms of JWA gene are associated with risk of bladder cancer. J Toxicol Environ Health A 2007; 70:876-884.
8. Tang WY, Wang L, Li C, et al. Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population. J Toxicol Environ Health A 2007; 70:885-894.
9. Cunha IW, Carvalho KC, Martins WK, et al. Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol 2010; 3:23-32.
10. Chen H, Bai J, Ye J, et al. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal 2007; 19:1315-1327.
11. Li Y, Tang Y, Ye L, et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003; 129:43-51.
12. Huang S, Shen Q, Mao WG, et al. JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci 2006; 13:357-371.
13. Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 2004; 130:460-468.
14. Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25:2586-2593.
15. Yang XR, Xu Y, Shi GM, et al. Cytokeratin 10 and cytokeratin 19: Predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin Cancer Res 2008; 14:3850-3859.
16. Li JC, Yang XR, Sun HX, et al. Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology 2010; 139:2146-2157.
17. Bai J, Zhang J, Wu J, et al. JWA regulates melanoma metastasis by integrin alpha(V)beta(3) signaling. Oncogene 2009; 29:1227-1237.
18. Chen R, Qiu W, Liu Z, et al. Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]pyrene and hydrogen peroxide. Free Radic Biol Med 2007; 42:1704-1714.
19. Zhou J, Ye J, Zhao X, Li A, Zhou J. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol Appl Pharmacol 2008; 230:33-40.
20. Wang S, Gong Z, Chen R, et al. JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks. Nucleic Acids Res 2009; 37:1936-1950.
21. Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9:416-423.
22. Siesser PM, Hanks SK. The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 2006; 12:3233-3237.
23. Zhai J, Lin H, Nie Z, et al. Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 2003; 278:24865-24873.
24. Chikumi H, Fukuhara S, Gutkind JS. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: Evidence of a role for focal adhesion kinase. J Biol Chem 2002; 277:12463-12473.
25. Hsia DA, Mitra SK, Hauck CR, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol 2003; 160:753-767.
26. Sakurai-Yageta M, Recchi C, Le Dez G, et al. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol 2008; 181:985-998.
27. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 2006; 20:2673-2686.
28. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997; 71:27-92.
29. Geerts D, Wallick CJ, Koomoa DL, et al. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: Correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation. Clin Cancer Res 2007; 13:6312-6319.
30. Wang S, Wu X, Chen Y, et al. Prognostic and predictive role of JWA and XRCC1 expression in gastric cancer. Clin Cancer Res 2012; 18:2987-2996.
31. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: A looking glass for cancer? Nat Rev Cancer 2012; 12:323-334.
32. Lee JS, Chu IS, Heo J, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004; 40:667-676.
33. Yamamoto K, Imamura H, Matsuyama Y, et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 2010; 45:1272-1282.
34. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 2004; 112:44-50.
35. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38:200-207.
36. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000; 31:302-308.
37. Taketa K. Alpha-fetoprotein: Reevaluation in hepatology. Hepatology 1990; 12:1420-1432.